IceCure Medical (ICCM) Shares Outstanding (Weighted Average) (2020 - 2026)
IceCure Medical (ICCM) reported Shares Outstanding (Weighted Average) of $60.0 for Q1 2026, little changed year-over-year from $60.0 in Q1 2025, and down 100.0% quarter-over-quarter from $63.6 million in Q4 2025.
IceCure Medical (ICCM) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends
IceCure Medical (ICCM) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $60.0 in Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $60.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $60.0 (changed 0.0% YoY), and the FY2025 annual result was $63.6 million, up 21192983.67% from the prior year.
- Shares Outstanding (Weighted Average) slipped to $60.0 in Q1 2026 per ICCM's latest filing, from $63.6 million in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $63.6 million in Q4 2025 and troughed at $60.0 in Q1 2025.
- A 5-year average of $8.6 million and a median of $180.0 in 2025 frame the typical range for Shares Outstanding (Weighted Average).
- The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Weighted Average) sank 100.0% in 2024, then jumped 21192983.67% in 2025.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $37.0 million in 2022, then rose by 23.29% to $45.6 million in 2023, then slumped by 100.0% to $300.0 in 2024, then jumped by 21192983.67% to $63.6 million in 2025, then slumped by 100.0% to $60.0 in 2026.
- Business Quant data shows ICCM's Shares Outstanding (Weighted Average) at $60.0 in Q1 2026, $63.6 million in Q4 2025, and $180.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 98.20 Mn |
| 10 | IceCure Medical | 334.80 | -8.11 Mn | 295,000.00 | 60.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.00 |
| Dec 31, 2025 | 63.58 Mn |
| Sep 30, 2025 | 180.00 |
| Jun 30, 2025 | 120.00 |
| Mar 31, 2025 | 60.00 |
| Dec 31, 2024 | 300.00 |
| Sep 30, 2024 | 220.00 |
| Jun 30, 2024 | 140.00 |
| Mar 31, 2024 | 80.00 |
| Dec 31, 2023 | 45.64 Mn |
| Sep 30, 2023 | 260.00 |
| Jun 30, 2023 | 170.00 |
| Mar 31, 2023 | 80.00 |
| Dec 31, 2022 | 37.02 Mn |
| Sep 30, 2022 | 354.00 |
| Jun 30, 2022 | 244.00 |
| Mar 31, 2022 | 120.00 |
| Dec 31, 2021 | 28.55 Mn |
| Sep 30, 2021 | 249.00 |
| Jun 30, 2021 | 156.00 |